165 related articles for article (PubMed ID: 28990506)
1. Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass Spectrometry.
Yumba-Mpanga A; Struck-Lewicka W; Wawrzyniak R; Markuszewski M; Roslan M; Kaliszan R; Markuszewski MJ
Curr Med Chem; 2019; 26(1):216-231. PubMed ID: 28990506
[TBL] [Abstract][Full Text] [Related]
2. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
3. Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry.
Konieczna L; Bączek T; Belka M; Fel A; Markuszewski M; Struck W; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2013 Jan; 73():108-15. PubMed ID: 22475516
[TBL] [Abstract][Full Text] [Related]
4. Targeted metabolomics in bladder cancer: From analytical methods development and validation towards application to clinical samples.
Yumba Mpanga A; Siluk D; Jacyna J; Szerkus O; Wawrzyniak R; Markuszewski M; Matuszewski M; Kaliszan R; Markuszewski MJ
Anal Chim Acta; 2018 Dec; 1037():188-199. PubMed ID: 30292293
[TBL] [Abstract][Full Text] [Related]
5. Advanced assessment of the endogenous hormone level as a potential biomarker of the urogenital tract cancer.
Konieczna L; Belka M; Baczek T; Ruszkowski M; Struck W; Markuszewski M; Kaliszan R; Markuszewski M
Comb Chem High Throughput Screen; 2013 Jul; 16(6):463-72. PubMed ID: 23410040
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
7. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
Zhang L; Li L; Kong H; Zeng F
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):763-6. PubMed ID: 26018279
[TBL] [Abstract][Full Text] [Related]
8. Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis.
Yu C; Niu L; Li L; Li T; Duan L; He Z; Zhao Y; Zou L; Wu X; Luo C
Prostate; 2021 Dec; 81(16):1320-1328. PubMed ID: 34590739
[TBL] [Abstract][Full Text] [Related]
9. LC/MS-based discrimination between plasma and urine metabolomic changes following exposure to ultraviolet radiation by using data modelling.
Ali AM; Monaghan C; Muggeridge DJ; Easton C; Watson DG
Metabolomics; 2023 Feb; 19(2):13. PubMed ID: 36781606
[TBL] [Abstract][Full Text] [Related]
10. Detection of inborn errors of metabolism utilizing GC-MS urinary metabolomics coupled with a modified orthogonal partial least squares discriminant analysis.
Yang Q; Lin SS; Yang JT; Tang LJ; Yu RQ
Talanta; 2017 Apr; 165():545-552. PubMed ID: 28153297
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
12. The potential role of fatty acids in prostate cancer determined by GC-MS analysis of formalin-fixed paraffin-embedded tissue samples.
Buszewska-Forajta M; Raczak-Gutknecht J; Artymowicz M; Wesołowski W; Buczkowski K; Iżycka-Świeszewska E; Markuszewski MJ
J Pharm Biomed Anal; 2021 Mar; 196():113907. PubMed ID: 33497978
[TBL] [Abstract][Full Text] [Related]
13. [A serum metabolomics study of gastric cancer based on pseudotargeted liquid chromatography-mass spectrometry approach].
Yang T; Luo P; Li Y; Hua R; Yin P; Xu G
Se Pu; 2014 Feb; 32(2):126-32. PubMed ID: 24822445
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
15. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
[TBL] [Abstract][Full Text] [Related]
16. Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry.
Li Q; Wei S; Wu D; Wen C; Zhou J
Biomed Res Int; 2018; 2018():3461572. PubMed ID: 30410926
[TBL] [Abstract][Full Text] [Related]
17. Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach.
Jacyna J; Wawrzyniak R; Balayssac S; Gilard V; Malet-Martino M; Sawicka A; Kordalewska M; Nowicki Ł; Kurek E; Bulska E; Patejko M; Markuszewski M; Gutknecht P; Matuszewski M; Siebert J; Kaliszan R; Markuszewski MJ
Talanta; 2019 Sep; 202():572-579. PubMed ID: 31171223
[TBL] [Abstract][Full Text] [Related]
18. Urinary metabolomics study the mechanism of Taohong Siwu Decoction intervention in acute blood stasis model rats based on liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Zhang X; Li P; Hua Y; Ji P; Yao W; Ma Q; Yuan Z; Wen Y; Yang C; Wei Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():51-60. PubMed ID: 29331744
[TBL] [Abstract][Full Text] [Related]
19. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]